CAPN2 and hepatocellular carcinoma: Results showed that CAPN2 mRNA expressions were significantly elevated in Lenvatinib-resistant HCC cell lines, whereas CAPN3, CAPN8 and CAPN15 mRNA expressions were lower in Lenvatinib-resistant HCC cell lines (P < 0.05, Fig. 1b).